Alprazolam
- Product NDC
- 65862-457
- 11-digit product format
- 658620457
- Labeler code
- 65862
- Product ID
- 65862-457_f2273fea-bd3b-4ef5-b698-73ba677722e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alprazolam
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA090871
- Marketing category
- ANDA
- Marketing start
- 2011-06-07
- Substance
- ALPRAZOLAM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alprazolam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALPRAZOLAM | 3 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YU55MQ3IZY |
| Rxcui | 433798, 433799, 433800, 433801 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65862-457-60 | Alprazolam | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 16 |
| 65862-457-71 | Alprazolam | 7000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 7000 | | 16 |
| 65862-457-99 | Alprazolam | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | | 16 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ALPRAZOLAM | ACTIVE INGREDIENT | YU55MQ3IZY | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| ALPRAZOLAM | ACTIVE MOIETY | YU55MQ3IZY | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| HYPROMELLOSE 2208 (100 MPA.S) | INACTIVE INGREDIENT | B1QE5P712K | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| HYPROMELLOSE 2208 (4000 MPA.S) | INACTIVE INGREDIENT | 39J80LT57T | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65862-457 | ALPRAZOLAM TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 14 | Current NDC, Legacy NDC, 3 package rows | 20230316_326fa31a-5420-429b-9f7f-170cb38f64bd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-457-60 | 65862045760 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-457-60) | 2011-06-07 | 0000-00-00 | No | No | Current |
| 65862-457-71 | 65862045771 | 7000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-457-71) | 2011-06-07 | 0000-00-00 | No | No | Current |
| 65862-457-99 | 65862045799 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-457-99) | 2011-06-07 | 0000-00-00 | No | No | Current |